Drug Trial Radar · NCT01203358
Exosurf Neonatal and Survanta for Treatment of Respiratory Distress Syndrome
Last checked: Nov 19, 2026Latest source record: Mar 22, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
617
Actual
Start
Jan 1991
Primary completion
Jan 1992
Study completion Jan 1992
Sponsor
- Lead sponsor
- NICHD Neonatal Research NetworkResearch network
- Sponsor type
- Research network
- First posted
- Sep 16, 2010
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, up to 6 hours
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare the efficacy of two surfactants, Exosurf Neonatal (Burroughs Wellcome Co.) and Survanta (Ross Laboratories), for the treatment of neonatal respiratory distress syndrome.
Conditions
- Infant, Newborn
- Infant, Low Birth Weight
- Infant, Small for Gestational Age
- Infant, Premature
- Bronchopulmonary Dysplasia
Interventions
ExosurfDrug
Infants received up to four intratracheal doses of the surfactant.
SurvantaDrug
Infants received up to four intratracheal doses of the surfactant.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Death or bronchopulmonary dysplasiaTime frame: 28 days of life
Locations
13 sites in 1 country. Site status is shown where the registry gives one.
Stanford University
Palo Alto, California
Yale University
New Haven, Connecticut
George Washington University
Washington D.C., District of Columbia
University of Miami
Miami, Florida
Emory University
Atlanta, Georgia
Indiana University
Indianapolis, Indiana
Wayne State University
Detroit, Michigan
University of New Mexico
Albuquerque, New Mexico
Cincinnati Children's Medical Center
Cincinnati, Ohio
Case Western Reserve University, Rainbow Babies and Children's Hospital
Cleveland, Ohio
University of Tennessee
Memphis, Tennessee
University of Texas Southwestern Medical Center at Dallas
Dallas, Texas
University of Vermont
Burlington, Vermont
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.